Images - Page 4
-
Feb. 29, 2024
P?l Hasvold, Medical Evidence Head, AstraZeneca was moderator of the plenary session "Health Data and Public Private Partnerships - How Competitive is Norway?" 14 February.
-
Feb. 29, 2024
CEO of Oslo Science City, Christine S?rbye Wergeland, Rector of The University of Oslo, Svein St?len and Carl Henrik G?rbitz, Director UiO:Life Science.
-
Feb. 16, 2024
Oddmund Hoel, Minister of Research and Higher Education opened Norway Life Science 2024.
-
Feb. 16, 2024
P?ivi Sillanaukee, Special Envoy for Health & Well-being, Ministry for Social Affairs and Health, Finland, participated in the session Nordic perspectives on health data.
-
Feb. 16, 2024
Katarina Nystr?m (Genomic Medicine Sweden), Andrew Morris (Health Data Research UK), P?ivi Sillanaukee (Ministry for Social Affairs and Health, Finland), Henrik Ullum (Statens Serum Institut, Denmark) participated in a panel discussion lead by Camilla Stoltenberg (Norce).
-
Feb. 16, 2024
Rasmus Figenschou, DNB and ?yvind S?tvedt, Department for Culture and Business Development, City of Oslo? in a dialogue about Attracting Talent and Investments.
-
Feb. 16, 2024
The city of Oslo invited all participants of Norway Life Science to a reception in Oslo City Hall.
-
Feb. 16, 2024
Speech by Svein St?len, Rector of the University of Oslo at the reception.
-
Feb. 16, 2024
Idar Kreutzer and Filippa Kull in dialogue with Henrik Ullum (Statens Serum Institut, Denmark) Johanna Lidén (AstraZeneca) Hanne Mette Dyrlie Kristensen (The Life Science Cluster) and Anette Steenberg (Medicon Valley Alliance).